Adjuvant denosumab for early breast cancer–Evidence and controversy

Adjuvant denosumab for early breast cancer–Evidence and controversy

The efficacy of adjuvant denosumab in combination with hormonotherapy in breast cancer patients was investigated in two randomized trials, ABCSG-18 and D-Care, but the results were mixed with respect to the impact of this drug on disease-free survival. However, the ABCSG-18 study has achieved its pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura Moretti, Laura Richelmi, Deborah Cosentini, Rebecca Pedersini, Salvatore Grisanti, Vito Amoroso, Alfredo Berruti, Marta Laganà
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977624001577
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items